Omnicell (OMCL) Liabilities and Shareholders Equity (2010 - 2026)

Omnicell (OMCL) has 17 years of Liabilities and Shareholders Equity data on file, last reported at $2.0 billion in Q1 2026.

• On a quarterly basis, Liabilities and Shareholders Equity fell 6.85% year-over-year to $2.0 billion in Q1 2026; TTM through Mar 2026 was $8.1 billion, a 8.96% decrease from a year earlier, with the FY2025 full-year figure at $2.0 billion, down 6.89% from the prior year.
• Liabilities and Shareholders Equity for Q1 2026 stood at $2.0 billion, up from $2.0 billion in the prior quarter.
• Over the last five years, Liabilities and Shareholders Equity for OMCL reached as high as $2.3 billion in Q3 2024 and fell as low as $1.9 billion in Q3 2025.
• Historically, Liabilities and Shareholders Equity has averaged $2.2 billion across 5 years, with a median of $2.2 billion in 2022.
• Across the five-year window, Liabilities and Shareholders Equity rose 12.51% in 2022 and fell 15.41% in 2025, its largest moves.
• Year by year, Liabilities and Shareholders Equity stood at $2.2 billion in 2022, then rose by 0.73% to $2.2 billion in 2023, then decreased by 4.76% to $2.1 billion in 2024, then fell by 6.89% to $2.0 billion in 2025, then rose by 1.49% to $2.0 billion in 2026.
• Per Business Quant data, the three most recent Liabilities and Shareholders Equity figures were $2.0 billion in Q1 2026, $2.0 billion in Q4 2025, and $1.9 billion in Q3 2025.